chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 46.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Arthralgia, Headache, Pain, Vaccination site pain
Clinical narrative: Injection site pain; Headache; Body aches; Joint pain; This is a spontaneous report from a contactable consumer, reporting for herself. A 46-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number: Ek9213), via an unspecified route of administration at the left arm on 15Jan2021 14:00 at single dose for COVID-19 immunization. Vaccination was done in a  health clinic. Medical history included diabetes, psoriasis, asthma and Covid (prior vaccination), all from an unknown date and unknown if ongoing. The patient was not pregnant. The patient had no known allergies. The patient's concomitant medications were not reported. On 16Jan2021 07:00, the patient experienced injection site pain, headache, body aches and joint pain.  No treatment was received. There was no other vaccine in four weeks. The patient has not had covid tested post vaccination. The outcome of the events was recovering.
Age: 66.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Abdominal pain upper, Headache, Joint swelling, Malaise, Muscle spasms
Clinical narrative: severe upper stomach pains and stomach pains all over and cramps; all over body pain; headache; nausea; ankles swelling more the right one; This is a spontaneous report from a contactable consumer (patient). A 66-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiration date not provided), via an unspecified route of administration in the right arm on 13Jan2021 13:00 at a single dose for COVID-19 immunization. Medical history included Coronary artery disease (CAD), 2nd degree AV heart block, acid reflux, gastritis, high blood presure, fibromyalgia, gammaglobulinemia, allergies to sulfa, eggs, milk, fish, shrimp, and nuts. The patient is not pregnant. The patient did not receive any other vaccine within 4 weeks prior to the COVID vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included valsartan (DIOVAN), esomeprazole sodium (NEXIUM), acetylsalicylic acid (BABY ASPIRIN), alprazolam, atorvastatin (LIPITOR). The patient previously took codeine, morphine, clopidogrel (PLAVIX), isosorbide mononitrate (IMDUR) and experienced allergies. On 13Jan2021 15:00, approximately 1 hour after the shot, the patient experienced severe upper stomach pains and stomach pains all over and cramps. A few hours later, she got all over body pain, headache, nausea, and her ankles were swelling more the right one. These events are all still going on 3 days later. Treatment was not provided in response to the events. The patient has not undergone COVID testing post vaccination.  The outcome of the events was not recovered.   Information on the lot/batch number has been requested.
Age: 66.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Nausea, Pain
Clinical narrative: severe upper stomach pains and stomach pains all over and cramps; all over body pain; headache; nausea; ankles swelling more the right one; This is a spontaneous report from a contactable consumer (patient). A 66-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiration date not provided), via an unspecified route of administration in the right arm on 13Jan2021 13:00 at a single dose for COVID-19 immunization. Medical history included Coronary artery disease (CAD), 2nd degree AV heart block, acid reflux, gastritis, high blood presure, fibromyalgia, gammaglobulinemia, allergies to sulfa, eggs, milk, fish, shrimp, and nuts. The patient is not pregnant. The patient did not receive any other vaccine within 4 weeks prior to the COVID vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included valsartan (DIOVAN), esomeprazole sodium (NEXIUM), acetylsalicylic acid (BABY ASPIRIN), alprazolam, atorvastatin (LIPITOR). The patient previously took codeine, morphine, clopidogrel (PLAVIX), isosorbide mononitrate (IMDUR) and experienced allergies. On 13Jan2021 15:00, approximately 1 hour after the shot, the patient experienced severe upper stomach pains and stomach pains all over and cramps. A few hours later, she got all over body pain, headache, nausea, and her ankles were swelling more the right one. These events are all still going on 3 days later. Treatment was not provided in response to the events. The patient has not undergone COVID testing post vaccination.  The outcome of the events was not recovered.   Information on the lot/batch number has been requested.
Age: 66.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Abdominal pain, Abdominal pain upper, Headache, Joint swelling, Nausea
Clinical narrative: severe upper stomach pains and stomach pains all over and cramps; all over body pain; headache; nausea; ankles swelling more the right one; This is a spontaneous report from a contactable consumer (patient). A 66-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiration date not provided), via an unspecified route of administration in the right arm on 13Jan2021 13:00 at a single dose for COVID-19 immunization. Medical history included Coronary artery disease (CAD), 2nd degree AV heart block, acid reflux, gastritis, high blood presure, fibromyalgia, gammaglobulinemia, allergies to sulfa, eggs, milk, fish, shrimp, and nuts. The patient is not pregnant. The patient did not receive any other vaccine within 4 weeks prior to the COVID vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included valsartan (DIOVAN), esomeprazole sodium (NEXIUM), acetylsalicylic acid (BABY ASPIRIN), alprazolam, atorvastatin (LIPITOR). The patient previously took codeine, morphine, clopidogrel (PLAVIX), isosorbide mononitrate (IMDUR) and experienced allergies. On 13Jan2021 15:00, approximately 1 hour after the shot, the patient experienced severe upper stomach pains and stomach pains all over and cramps. A few hours later, she got all over body pain, headache, nausea, and her ankles were swelling more the right one. These events are all still going on 3 days later. Treatment was not provided in response to the events. The patient has not undergone COVID testing post vaccination.  The outcome of the events was not recovered.   Information on the lot/batch number has been requested.
Age: 66.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Pain
Clinical narrative: severe upper stomach pains and stomach pains all over and cramps; all over body pain; headache; nausea; ankles swelling more the right one; This is a spontaneous report from a contactable consumer (patient). A 66-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiration date not provided), via an unspecified route of administration in the right arm on 13Jan2021 13:00 at a single dose for COVID-19 immunization. Medical history included Coronary artery disease (CAD), 2nd degree AV heart block, acid reflux, gastritis, high blood presure, fibromyalgia, gammaglobulinemia, allergies to sulfa, eggs, milk, fish, shrimp, and nuts. The patient is not pregnant. The patient did not receive any other vaccine within 4 weeks prior to the COVID vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included valsartan (DIOVAN), esomeprazole sodium (NEXIUM), acetylsalicylic acid (BABY ASPIRIN), alprazolam, atorvastatin (LIPITOR). The patient previously took codeine, morphine, clopidogrel (PLAVIX), isosorbide mononitrate (IMDUR) and experienced allergies. On 13Jan2021 15:00, approximately 1 hour after the shot, the patient experienced severe upper stomach pains and stomach pains all over and cramps. A few hours later, she got all over body pain, headache, nausea, and her ankles were swelling more the right one. These events are all still going on 3 days later. Treatment was not provided in response to the events. The patient has not undergone COVID testing post vaccination.  The outcome of the events was not recovered.   Information on the lot/batch number has been requested.
Age: 78.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Fatigue, Malaise, Nausea
Clinical narrative: Nausea; Tiredness; Feeling Unwell; This is a spontaneous report from a contactable consumer reporting for himself. A 78-year-old male patient received bnt162b2 (BNT162B2, lot number and expiry date were unknown), on 15Jan2021 at 09:15 AM on the right arm for COVID-19 immunization. The vaccine was administered at a living facility. The patient had not received other vaccines in four weeks prior to receiving bnt162b2. Medical history was not reported. He had no known allergies. Concomitant medications included unspecified medications (other medications in two weeks: yes). The patient did not have covid prior to vaccination and was not tested for covid post vaccination. The patient experienced nausea, tiredness and feeling unwell on 16Jan2021 10:00 AM. The patient did not receive any treatment for the reported adverse events. Outcome of the events was recovering.  Information on the Lot/Batch number has been requested.
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Ageusia, Anosmia, Back pain, COVID-19, Chills
Clinical narrative: COVID-19 virus test positive; COVID-19 virus test positive; This is a spontaneous report from a Pfizer-sponsored program contactable consumer reporting for herself. A 53-year-old female patient received the 1st dose of bnt162b2 (BNT162B2, Manufacturer Pfizer-BioNTech), via an unspecified route of administration, on an unspecified date, at single dose, for COVID-19 immunisation. Medical history included blood pressure. Concomitant medication included losartan (unknown manufacturer) for blood pressure. The patient experienced COVID-19 virus test positive on an unspecified date with outcome of unknown. The patient underwent lab tests and procedures which included COVID-19 virus test: positive (unknown date).  The information on the lot/batch number has been requested.
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Cough, Impaired work ability, Pyrexia, Respiratory tract congestion, SARS-CoV-2 test negative
Clinical narrative: COVID-19 virus test positive; COVID-19 virus test positive; This is a spontaneous report from a Pfizer-sponsored program contactable consumer reporting for herself. A 53-year-old female patient received the 1st dose of bnt162b2 (BNT162B2, Manufacturer Pfizer-BioNTech), via an unspecified route of administration, on an unspecified date, at single dose, for COVID-19 immunisation. Medical history included blood pressure. Concomitant medication included losartan (unknown manufacturer) for blood pressure. The patient experienced COVID-19 virus test positive on an unspecified date with outcome of unknown. The patient underwent lab tests and procedures which included COVID-19 virus test: positive (unknown date).  The information on the lot/batch number has been requested.
Sex: F
Vaccine: COVID19, COVID19
Symptoms: SARS-CoV-2 test positive
Clinical narrative: COVID-19 virus test positive; COVID-19 virus test positive; This is a spontaneous report from a Pfizer-sponsored program contactable consumer reporting for herself. A 53-year-old female patient received the 1st dose of bnt162b2 (BNT162B2, Manufacturer Pfizer-BioNTech), via an unspecified route of administration, on an unspecified date, at single dose, for COVID-19 immunisation. Medical history included blood pressure. Concomitant medication included losartan (unknown manufacturer) for blood pressure. The patient experienced COVID-19 virus test positive on an unspecified date with outcome of unknown. The patient underwent lab tests and procedures which included COVID-19 virus test: positive (unknown date).  The information on the lot/batch number has been requested.
Sex: F
Vaccine: COVID19, COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: COVID-19 virus test positive; COVID-19 virus test positive; This is a spontaneous report from a Pfizer-sponsored program contactable consumer reporting for herself. A 53-year-old female patient received the 1st dose of bnt162b2 (BNT162B2, Manufacturer Pfizer-BioNTech), via an unspecified route of administration, on an unspecified date, at single dose, for COVID-19 immunisation. Medical history included blood pressure. Concomitant medication included losartan (unknown manufacturer) for blood pressure. The patient experienced COVID-19 virus test positive on an unspecified date with outcome of unknown. The patient underwent lab tests and procedures which included COVID-19 virus test: positive (unknown date).  The information on the lot/batch number has been requested.
Age: 45.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Axillary mass, Decreased appetite, Eye pain, Headache, Lymphadenopathy
Clinical narrative: nausea; left upper arm/underarm/breast swelling and pain; left upper arm/underarm/breast swelling and pain; left upper arm/underarm/breast swelling and pain; left upper arm/underarm/breast swelling and pain; left upper arm/underarm/breast swelling and pain; headache; body aches at the slightest touch; fever; loss of appetite lasting 4 days; left upper arm/underarm/breast swelling and pain; This is a spontaneous report from a contactable other healthcare professional (patient). A 45-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL8982 and expiration date not provided), intramuscular in the left arm on 14Jan2021 12:30 at a single dose for COVID-19 immunization. Medical history included hypertension (HTN) and hypothyroidism. The patient is not pregnant. The patient has no know allergies. There were no concomitant medications. The patient did not receive any other vaccine within 4 weeks prior to the COVID vaccine and no other medications in two weeks. Prior to the vaccination, the patient was not diagnosed with COVID-19. On 15Jan2021 02:45, the patient experienced nausea, left upper arm/underarm/breast swelling and pain, headache nothing would take away, body aches at the slightest touch, fever, loss of appetite lasting 4 days and still with nausea, loss of appetite and headache. Treatment was not provided in response to the events. The outcome of the events was recovered with sequelae on an unspecified date in Jan2021. The patient has not been tested for COVID post vaccination.
Age: 45.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Nausea, Pain, Pain of skin
Clinical narrative: nausea; left upper arm/underarm/breast swelling and pain; left upper arm/underarm/breast swelling and pain; left upper arm/underarm/breast swelling and pain; left upper arm/underarm/breast swelling and pain; left upper arm/underarm/breast swelling and pain; headache; body aches at the slightest touch; fever; loss of appetite lasting 4 days; left upper arm/underarm/breast swelling and pain; This is a spontaneous report from a contactable other healthcare professional (patient). A 45-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL8982 and expiration date not provided), intramuscular in the left arm on 14Jan2021 12:30 at a single dose for COVID-19 immunization. Medical history included hypertension (HTN) and hypothyroidism. The patient is not pregnant. The patient has no know allergies. There were no concomitant medications. The patient did not receive any other vaccine within 4 weeks prior to the COVID vaccine and no other medications in two weeks. Prior to the vaccination, the patient was not diagnosed with COVID-19. On 15Jan2021 02:45, the patient experienced nausea, left upper arm/underarm/breast swelling and pain, headache nothing would take away, body aches at the slightest touch, fever, loss of appetite lasting 4 days and still with nausea, loss of appetite and headache. Treatment was not provided in response to the events. The outcome of the events was recovered with sequelae on an unspecified date in Jan2021. The patient has not been tested for COVID post vaccination.
Age: 45.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Axillary pain, Breast pain, Breast swelling, Decreased appetite, Headache
Clinical narrative: nausea; left upper arm/underarm/breast swelling and pain; left upper arm/underarm/breast swelling and pain; left upper arm/underarm/breast swelling and pain; left upper arm/underarm/breast swelling and pain; left upper arm/underarm/breast swelling and pain; headache; body aches at the slightest touch; fever; loss of appetite lasting 4 days; left upper arm/underarm/breast swelling and pain; This is a spontaneous report from a contactable other healthcare professional (patient). A 45-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL8982 and expiration date not provided), intramuscular in the left arm on 14Jan2021 12:30 at a single dose for COVID-19 immunization. Medical history included hypertension (HTN) and hypothyroidism. The patient is not pregnant. The patient has no know allergies. There were no concomitant medications. The patient did not receive any other vaccine within 4 weeks prior to the COVID vaccine and no other medications in two weeks. Prior to the vaccination, the patient was not diagnosed with COVID-19. On 15Jan2021 02:45, the patient experienced nausea, left upper arm/underarm/breast swelling and pain, headache nothing would take away, body aches at the slightest touch, fever, loss of appetite lasting 4 days and still with nausea, loss of appetite and headache. Treatment was not provided in response to the events. The outcome of the events was recovered with sequelae on an unspecified date in Jan2021. The patient has not been tested for COVID post vaccination.
Age: 45.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Nausea, Pain, Pain in extremity, Peripheral swelling, Pyrexia
Clinical narrative: nausea; left upper arm/underarm/breast swelling and pain; left upper arm/underarm/breast swelling and pain; left upper arm/underarm/breast swelling and pain; left upper arm/underarm/breast swelling and pain; left upper arm/underarm/breast swelling and pain; headache; body aches at the slightest touch; fever; loss of appetite lasting 4 days; left upper arm/underarm/breast swelling and pain; This is a spontaneous report from a contactable other healthcare professional (patient). A 45-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL8982 and expiration date not provided), intramuscular in the left arm on 14Jan2021 12:30 at a single dose for COVID-19 immunization. Medical history included hypertension (HTN) and hypothyroidism. The patient is not pregnant. The patient has no know allergies. There were no concomitant medications. The patient did not receive any other vaccine within 4 weeks prior to the COVID vaccine and no other medications in two weeks. Prior to the vaccination, the patient was not diagnosed with COVID-19. On 15Jan2021 02:45, the patient experienced nausea, left upper arm/underarm/breast swelling and pain, headache nothing would take away, body aches at the slightest touch, fever, loss of appetite lasting 4 days and still with nausea, loss of appetite and headache. Treatment was not provided in response to the events. The outcome of the events was recovered with sequelae on an unspecified date in Jan2021. The patient has not been tested for COVID post vaccination.
Age: 45.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Swelling
Clinical narrative: nausea; left upper arm/underarm/breast swelling and pain; left upper arm/underarm/breast swelling and pain; left upper arm/underarm/breast swelling and pain; left upper arm/underarm/breast swelling and pain; left upper arm/underarm/breast swelling and pain; headache; body aches at the slightest touch; fever; loss of appetite lasting 4 days; left upper arm/underarm/breast swelling and pain; This is a spontaneous report from a contactable other healthcare professional (patient). A 45-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL8982 and expiration date not provided), intramuscular in the left arm on 14Jan2021 12:30 at a single dose for COVID-19 immunization. Medical history included hypertension (HTN) and hypothyroidism. The patient is not pregnant. The patient has no know allergies. There were no concomitant medications. The patient did not receive any other vaccine within 4 weeks prior to the COVID vaccine and no other medications in two weeks. Prior to the vaccination, the patient was not diagnosed with COVID-19. On 15Jan2021 02:45, the patient experienced nausea, left upper arm/underarm/breast swelling and pain, headache nothing would take away, body aches at the slightest touch, fever, loss of appetite lasting 4 days and still with nausea, loss of appetite and headache. Treatment was not provided in response to the events. The outcome of the events was recovered with sequelae on an unspecified date in Jan2021. The patient has not been tested for COVID post vaccination.
Age: 79.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Chills, Decreased appetite, Feeling cold, Malaise, Nausea
Clinical narrative: Fever102.4, chills, aches. Went to the hospital on 1/11/21
Age: 79.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Pyrexia
Clinical narrative: Fever102.4, chills, aches. Went to the hospital on 1/11/21
Age: 79.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Chills, Pain, Pyrexia
Clinical narrative: Fever102.4, chills, aches. Went to the hospital on 1/11/21
Age: 45.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Burning sensation, Peripheral swelling, Pruritus, Rash, Swelling
Clinical narrative: Rash to groin, legs, parts of torso; swelling to hands, feet and legs; This is a spontaneous report received from a contactable nurse (who is also the patient). A 45-year-old male patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL3302, expiry date: unknown), intramuscular in the right arm, on 14Jan2021 07:45, at single dose, for COVID-19 immunization, in the hospital. Medical history included hypertension. The patient has no known allergies. The patient did not have COVID-19 prior to vaccination. Concomitant medication included losartan potassium (COZAAR). Historical vaccine included the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EH9899, expiry date: unknown), intramuscular in the right arm, for COVID-19 immunization. On 16Jan2021 at 06:00, the patient experienced rash to groin, legs, parts of torso and also swelling to hands, feet and legs. No treatment was given for the events. The patient was not tested for COVID-19 post vaccination. The outcome of the events was unknown.
Age: 45.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Peripheral swelling, Rash
Clinical narrative: Rash to groin, legs, parts of torso; swelling to hands, feet and legs; This is a spontaneous report received from a contactable nurse (who is also the patient). A 45-year-old male patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL3302, expiry date: unknown), intramuscular in the right arm, on 14Jan2021 07:45, at single dose, for COVID-19 immunization, in the hospital. Medical history included hypertension. The patient has no known allergies. The patient did not have COVID-19 prior to vaccination. Concomitant medication included losartan potassium (COZAAR). Historical vaccine included the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EH9899, expiry date: unknown), intramuscular in the right arm, for COVID-19 immunization. On 16Jan2021 at 06:00, the patient experienced rash to groin, legs, parts of torso and also swelling to hands, feet and legs. No treatment was given for the events. The patient was not tested for COVID-19 post vaccination. The outcome of the events was unknown.
Age: 49.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Ageusia, Anosmia, COVID-19, Chills, Cough
Clinical narrative: Sick; Tested positive after receiving the first dose; Tested positive after receiving the first dose; Dry cough after first dose; This is a spontaneous report from a contactable consumer. A female patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, batch/lot number EK7530), via an unspecified route of administration on 21Dec2020 at single dose for covid-19 immunisation. The patient medical history was not reported.  There were no concomitant medications.  The patient received the first dose on 21Dec2020. She became sick with a dry cough. She tested positive for Covid after receiving the first dose. She received the second dose on 11Jan2021. She started having fever, chills and a headache. It was administered in the left arm. She returned to work on 06Jan2021. The headaches come and go in waves. She was tired and took a nap and woke feeling not good. She is now taking B12 and it is helping her.  The patient underwent lab tests and procedures which included sars-cov-2 test: positive on 28Dec2020.  The outcome of the event Dry cough after first dose was resolving while the outcome of the other events was unknown.
Age: 49.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Headache, Injection site pain, Pain, Pyrexia
Clinical narrative: Sick; Tested positive after receiving the first dose; Tested positive after receiving the first dose; Dry cough after first dose; This is a spontaneous report from a contactable consumer. A female patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, batch/lot number EK7530), via an unspecified route of administration on 21Dec2020 at single dose for covid-19 immunisation. The patient medical history was not reported.  There were no concomitant medications.  The patient received the first dose on 21Dec2020. She became sick with a dry cough. She tested positive for Covid after receiving the first dose. She received the second dose on 11Jan2021. She started having fever, chills and a headache. It was administered in the left arm. She returned to work on 06Jan2021. The headaches come and go in waves. She was tired and took a nap and woke feeling not good. She is now taking B12 and it is helping her.  The patient underwent lab tests and procedures which included sars-cov-2 test: positive on 28Dec2020.  The outcome of the event Dry cough after first dose was resolving while the outcome of the other events was unknown.
Age: 49.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Cough, Drug ineffective, Illness, SARS-CoV-2 test, SARS-CoV-2 test positive
Clinical narrative: Sick; Tested positive after receiving the first dose; Tested positive after receiving the first dose; Dry cough after first dose; This is a spontaneous report from a contactable consumer. A female patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, batch/lot number EK7530), via an unspecified route of administration on 21Dec2020 at single dose for covid-19 immunisation. The patient medical history was not reported.  There were no concomitant medications.  The patient received the first dose on 21Dec2020. She became sick with a dry cough. She tested positive for Covid after receiving the first dose. She received the second dose on 11Jan2021. She started having fever, chills and a headache. It was administered in the left arm. She returned to work on 06Jan2021. The headaches come and go in waves. She was tired and took a nap and woke feeling not good. She is now taking B12 and it is helping her.  The patient underwent lab tests and procedures which included sars-cov-2 test: positive on 28Dec2020.  The outcome of the event Dry cough after first dose was resolving while the outcome of the other events was unknown.
Age: 56.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Asthenia, Balance disorder, Blood pressure increased, Disturbance in attention, Fatigue
Clinical narrative: Generalized weakness; Numbness in lower lip; Prolonged malaise; Headaches; Poor equilibrium; Chest pain; Persistent increase in blood pressure; Intermittent tachycardia; This is a spontaneous report from a contactable nurse. This nurse reported for herself that the 56-year-old female patient who received  econd dose of bnt162b2 (BNT162B2, COVID 19 Pfizer) via Intramuscular on 07Jan2021 04:00 PM on Left Arm at a single dose  for covid-19 immunization. She is not pregnant. Medical history included Known allergies: Taxotere and Breast cancer. Concomitant medications included Tamoxifen. The patient previously took first dose of bnt162b2 at a single dose for covid-19 immunization.  Facility type vaccine was Hospital. No other vaccine in four weeks. The patient experienced Generalized weakness Numbness in lower lip Prolonged malaise Headaches Poor equilibrium Chest pain Persistent increase in blood pressure Intermittent tachycardia from 08Jan2021 3:00 PM. AE resulted in: Doctor or other healthcare professional office/clinic visit, Emergency room/department or urgent care. The outcome of the event was unknown. No treatment received. No COVID prior vaccination. COVID tested post vaccination included Covid test post vaccination: Nasal Swab, PCR panel on 12Jan2021 with covid test result: Negative.   Information Requested on Lot/ batch number.
Age: 56.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Hypoaesthesia oral, Laboratory test, Pyrexia, Tachycardia
Clinical narrative: Generalized weakness; Numbness in lower lip; Prolonged malaise; Headaches; Poor equilibrium; Chest pain; Persistent increase in blood pressure; Intermittent tachycardia; This is a spontaneous report from a contactable nurse. This nurse reported for herself that the 56-year-old female patient who received  econd dose of bnt162b2 (BNT162B2, COVID 19 Pfizer) via Intramuscular on 07Jan2021 04:00 PM on Left Arm at a single dose  for covid-19 immunization. She is not pregnant. Medical history included Known allergies: Taxotere and Breast cancer. Concomitant medications included Tamoxifen. The patient previously took first dose of bnt162b2 at a single dose for covid-19 immunization.  Facility type vaccine was Hospital. No other vaccine in four weeks. The patient experienced Generalized weakness Numbness in lower lip Prolonged malaise Headaches Poor equilibrium Chest pain Persistent increase in blood pressure Intermittent tachycardia from 08Jan2021 3:00 PM. AE resulted in: Doctor or other healthcare professional office/clinic visit, Emergency room/department or urgent care. The outcome of the event was unknown. No treatment received. No COVID prior vaccination. COVID tested post vaccination included Covid test post vaccination: Nasal Swab, PCR panel on 12Jan2021 with covid test result: Negative.   Information Requested on Lot/ batch number.
Age: 56.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Asthenia, Balance disorder, Blood pressure increased, Blood pressure measurement, Chest pain
Clinical narrative: Generalized weakness; Numbness in lower lip; Prolonged malaise; Headaches; Poor equilibrium; Chest pain; Persistent increase in blood pressure; Intermittent tachycardia; This is a spontaneous report from a contactable nurse. This nurse reported for herself that the 56-year-old female patient who received  econd dose of bnt162b2 (BNT162B2, COVID 19 Pfizer) via Intramuscular on 07Jan2021 04:00 PM on Left Arm at a single dose  for covid-19 immunization. She is not pregnant. Medical history included Known allergies: Taxotere and Breast cancer. Concomitant medications included Tamoxifen. The patient previously took first dose of bnt162b2 at a single dose for covid-19 immunization.  Facility type vaccine was Hospital. No other vaccine in four weeks. The patient experienced Generalized weakness Numbness in lower lip Prolonged malaise Headaches Poor equilibrium Chest pain Persistent increase in blood pressure Intermittent tachycardia from 08Jan2021 3:00 PM. AE resulted in: Doctor or other healthcare professional office/clinic visit, Emergency room/department or urgent care. The outcome of the event was unknown. No treatment received. No COVID prior vaccination. COVID tested post vaccination included Covid test post vaccination: Nasal Swab, PCR panel on 12Jan2021 with covid test result: Negative.   Information Requested on Lot/ batch number.
Age: 56.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Headache, Hypoaesthesia oral, Malaise, SARS-CoV-2 test, Tachycardia
Clinical narrative: Generalized weakness; Numbness in lower lip; Prolonged malaise; Headaches; Poor equilibrium; Chest pain; Persistent increase in blood pressure; Intermittent tachycardia; This is a spontaneous report from a contactable nurse. This nurse reported for herself that the 56-year-old female patient who received  econd dose of bnt162b2 (BNT162B2, COVID 19 Pfizer) via Intramuscular on 07Jan2021 04:00 PM on Left Arm at a single dose  for covid-19 immunization. She is not pregnant. Medical history included Known allergies: Taxotere and Breast cancer. Concomitant medications included Tamoxifen. The patient previously took first dose of bnt162b2 at a single dose for covid-19 immunization.  Facility type vaccine was Hospital. No other vaccine in four weeks. The patient experienced Generalized weakness Numbness in lower lip Prolonged malaise Headaches Poor equilibrium Chest pain Persistent increase in blood pressure Intermittent tachycardia from 08Jan2021 3:00 PM. AE resulted in: Doctor or other healthcare professional office/clinic visit, Emergency room/department or urgent care. The outcome of the event was unknown. No treatment received. No COVID prior vaccination. COVID tested post vaccination included Covid test post vaccination: Nasal Swab, PCR panel on 12Jan2021 with covid test result: Negative.   Information Requested on Lot/ batch number.
Age: 74.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Dizziness, Feeling abnormal
Clinical narrative: Approximately  84 hours after administration, I had severe vertigo when prone.  This included a strange sensation of my head floating and an odd sense of loosing consciousness.  The vertigo was awful, and I could barely stand.  This lasted each evening for about 6 night.  It subsided in the morning, after I felt more stabilized in walking.
Age: 74.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Dysstasia, Feeling abnormal, Loss of consciousness, Magnetic resonance imaging head normal, Vertigo
Clinical narrative: Approximately  84 hours after administration, I had severe vertigo when prone.  This included a strange sensation of my head floating and an odd sense of loosing consciousness.  The vertigo was awful, and I could barely stand.  This lasted each evening for about 6 night.  It subsided in the morning, after I felt more stabilized in walking.
Age: 46.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Arthralgia, Nausea, Pruritus
Clinical narrative: Complaints of itching neck, scalp, no rash. Denies shortness of breath, chest pain, difficulty breathing.  Vital Signs : blood pressure 136/90, pulse 86, oxygen saturation 100% on room air.
Age: 46.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Pruritus
Clinical narrative: Complaints of itching neck, scalp, no rash. Denies shortness of breath, chest pain, difficulty breathing.  Vital Signs : blood pressure 136/90, pulse 86, oxygen saturation 100% on room air.
Age: 58.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Lip swelling, Paraesthesia oral
Clinical narrative: Metalic taste in throat Burning in chest lips swelling tongue swelling with swallow difficulty
Age: 58.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Chest pain, Dysgeusia, Dysphagia, Lip swelling, Swollen tongue
Clinical narrative: Metalic taste in throat Burning in chest lips swelling tongue swelling with swallow difficulty
Age: 22.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Bell's palsy
Clinical narrative: Patient reported to ED 24 Jan 2021 with Bell's Palsy symptoms on right side of face 23 Jan 2021.  Patient given eye drops, steroids and antivirals.
Age: 47.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Abdominal discomfort, Chills, Dizziness, Fatigue, Feeling abnormal
Clinical narrative: Immediately within minutes had tingling in back of throat which persists to today Headache began day 1, lightheaded ness, severe chills c shaking, hot flashes with hot hands, nasal congestion, draining, circulatory changes with hand and feet discoloration and skin mottling, diarrhea x 1.5 weeks, swelling in mouth and throat, nausea, loss of appetite, lightheadedness, tingling from head to toe: went to ER for fluid IV/and potassium due to low potassium.
Age: 47.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Headache, Heart rate increased, Hyperhidrosis, Mobility decreased, Nasal congestion
Clinical narrative: Immediately within minutes had tingling in back of throat which persists to today Headache began day 1, lightheaded ness, severe chills c shaking, hot flashes with hot hands, nasal congestion, draining, circulatory changes with hand and feet discoloration and skin mottling, diarrhea x 1.5 weeks, swelling in mouth and throat, nausea, loss of appetite, lightheadedness, tingling from head to toe: went to ER for fluid IV/and potassium due to low potassium.
Age: 47.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Pain in extremity, Rhinorrhoea, Throat irritation
Clinical narrative: Immediately within minutes had tingling in back of throat which persists to today Headache began day 1, lightheaded ness, severe chills c shaking, hot flashes with hot hands, nasal congestion, draining, circulatory changes with hand and feet discoloration and skin mottling, diarrhea x 1.5 weeks, swelling in mouth and throat, nausea, loss of appetite, lightheadedness, tingling from head to toe: went to ER for fluid IV/and potassium due to low potassium.
Age: 47.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Blood potassium decreased, Blood thyroid stimulating hormone, C-reactive protein normal, Chills, Decreased appetite
Clinical narrative: Immediately within minutes had tingling in back of throat which persists to today Headache began day 1, lightheaded ness, severe chills c shaking, hot flashes with hot hands, nasal congestion, draining, circulatory changes with hand and feet discoloration and skin mottling, diarrhea x 1.5 weeks, swelling in mouth and throat, nausea, loss of appetite, lightheadedness, tingling from head to toe: went to ER for fluid IV/and potassium due to low potassium.
Age: 47.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Diarrhoea, Dizziness, Drainage, Feeling hot, Full blood count normal
Clinical narrative: Immediately within minutes had tingling in back of throat which persists to today Headache began day 1, lightheaded ness, severe chills c shaking, hot flashes with hot hands, nasal congestion, draining, circulatory changes with hand and feet discoloration and skin mottling, diarrhea x 1.5 weeks, swelling in mouth and throat, nausea, loss of appetite, lightheadedness, tingling from head to toe: went to ER for fluid IV/and potassium due to low potassium.
Age: 47.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Headache, Hot flush, Immediate post-injection reaction, Influenza A virus test negative, Influenza B virus test
Clinical narrative: Immediately within minutes had tingling in back of throat which persists to today Headache began day 1, lightheaded ness, severe chills c shaking, hot flashes with hot hands, nasal congestion, draining, circulatory changes with hand and feet discoloration and skin mottling, diarrhea x 1.5 weeks, swelling in mouth and throat, nausea, loss of appetite, lightheadedness, tingling from head to toe: went to ER for fluid IV/and potassium due to low potassium.
Age: 47.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Livedo reticularis, Mouth swelling, Nasal congestion, Nausea, Paraesthesia
Clinical narrative: Immediately within minutes had tingling in back of throat which persists to today Headache began day 1, lightheaded ness, severe chills c shaking, hot flashes with hot hands, nasal congestion, draining, circulatory changes with hand and feet discoloration and skin mottling, diarrhea x 1.5 weeks, swelling in mouth and throat, nausea, loss of appetite, lightheadedness, tingling from head to toe: went to ER for fluid IV/and potassium due to low potassium.
Age: 47.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Peripheral vascular disorder, Pharyngeal paraesthesia, Pharyngeal swelling, Polymerase chain reaction, SARS-CoV-2 test negative
Clinical narrative: Immediately within minutes had tingling in back of throat which persists to today Headache began day 1, lightheaded ness, severe chills c shaking, hot flashes with hot hands, nasal congestion, draining, circulatory changes with hand and feet discoloration and skin mottling, diarrhea x 1.5 weeks, swelling in mouth and throat, nausea, loss of appetite, lightheadedness, tingling from head to toe: went to ER for fluid IV/and potassium due to low potassium.
Age: 47.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Skin discolouration, Thyroxine increased, Tremor, Urine analysis
Clinical narrative: Immediately within minutes had tingling in back of throat which persists to today Headache began day 1, lightheaded ness, severe chills c shaking, hot flashes with hot hands, nasal congestion, draining, circulatory changes with hand and feet discoloration and skin mottling, diarrhea x 1.5 weeks, swelling in mouth and throat, nausea, loss of appetite, lightheadedness, tingling from head to toe: went to ER for fluid IV/and potassium due to low potassium.
Age: 24.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Pharyngeal swelling
Clinical narrative: 12/26/20 1st dose - itching for 2 weeks Claritin for 2 weeks, ibuprofen and Tylenol as needed  1/21/21 2nd dose 0737 - injection  0740 - feeling like the back of the throat has something stuck. 0740-0750 difficultly breathing, throat tightness, back of mouth swelling, cool and pale hands, tingling in legs.  Went to ER IV solumedrol, IV Benadryl, IV pepcid, SQ epinephrine  0800-0900  Breathing better, occasional throat tightness on and off. Admitted overnight  for observation   1/22/21 0200  Throat swelling came back and having trouble breathing IV Benadryl, IV solumedrol  1400 Discharge home with 20 mg prednisone for 5 days, Pepcid, and epi pen  1/27/21 prednisone course completed at 0900  1/28/21 0300 - throat tightness, difficulty breathing, cool and pale hands, left arm tingling, legs tingling, and dizziness Administered EPI and went to ER  0300 to 0700  Observation in ER IV solumedrol, IV Benadryl, IV Pepcid  0700 discharge home with tapered medrol pack, Pepcid, and epi pen.  01/28/21 1800 start of medrol   2/2/21 end of medrol and follow with pcp as needed
Age: 24.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Dizziness, Dyspnoea, Feeling cold, Full blood count, Metabolic function test
Clinical narrative: 12/26/20 1st dose - itching for 2 weeks Claritin for 2 weeks, ibuprofen and Tylenol as needed  1/21/21 2nd dose 0737 - injection  0740 - feeling like the back of the throat has something stuck. 0740-0750 difficultly breathing, throat tightness, back of mouth swelling, cool and pale hands, tingling in legs.  Went to ER IV solumedrol, IV Benadryl, IV pepcid, SQ epinephrine  0800-0900  Breathing better, occasional throat tightness on and off. Admitted overnight  for observation   1/22/21 0200  Throat swelling came back and having trouble breathing IV Benadryl, IV solumedrol  1400 Discharge home with 20 mg prednisone for 5 days, Pepcid, and epi pen  1/27/21 prednisone course completed at 0900  1/28/21 0300 - throat tightness, difficulty breathing, cool and pale hands, left arm tingling, legs tingling, and dizziness Administered EPI and went to ER  0300 to 0700  Observation in ER IV solumedrol, IV Benadryl, IV Pepcid  0700 discharge home with tapered medrol pack, Pepcid, and epi pen.  01/28/21 1800 start of medrol   2/2/21 end of medrol and follow with pcp as needed
Age: 24.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Mouth swelling, Pallor, Paraesthesia, Peripheral coldness, Pharyngeal swelling
Clinical narrative: 12/26/20 1st dose - itching for 2 weeks Claritin for 2 weeks, ibuprofen and Tylenol as needed  1/21/21 2nd dose 0737 - injection  0740 - feeling like the back of the throat has something stuck. 0740-0750 difficultly breathing, throat tightness, back of mouth swelling, cool and pale hands, tingling in legs.  Went to ER IV solumedrol, IV Benadryl, IV pepcid, SQ epinephrine  0800-0900  Breathing better, occasional throat tightness on and off. Admitted overnight  for observation   1/22/21 0200  Throat swelling came back and having trouble breathing IV Benadryl, IV solumedrol  1400 Discharge home with 20 mg prednisone for 5 days, Pepcid, and epi pen  1/27/21 prednisone course completed at 0900  1/28/21 0300 - throat tightness, difficulty breathing, cool and pale hands, left arm tingling, legs tingling, and dizziness Administered EPI and went to ER  0300 to 0700  Observation in ER IV solumedrol, IV Benadryl, IV Pepcid  0700 discharge home with tapered medrol pack, Pepcid, and epi pen.  01/28/21 1800 start of medrol   2/2/21 end of medrol and follow with pcp as needed
Age: 24.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Sensation of foreign body, Throat tightness
Clinical narrative: 12/26/20 1st dose - itching for 2 weeks Claritin for 2 weeks, ibuprofen and Tylenol as needed  1/21/21 2nd dose 0737 - injection  0740 - feeling like the back of the throat has something stuck. 0740-0750 difficultly breathing, throat tightness, back of mouth swelling, cool and pale hands, tingling in legs.  Went to ER IV solumedrol, IV Benadryl, IV pepcid, SQ epinephrine  0800-0900  Breathing better, occasional throat tightness on and off. Admitted overnight  for observation   1/22/21 0200  Throat swelling came back and having trouble breathing IV Benadryl, IV solumedrol  1400 Discharge home with 20 mg prednisone for 5 days, Pepcid, and epi pen  1/27/21 prednisone course completed at 0900  1/28/21 0300 - throat tightness, difficulty breathing, cool and pale hands, left arm tingling, legs tingling, and dizziness Administered EPI and went to ER  0300 to 0700  Observation in ER IV solumedrol, IV Benadryl, IV Pepcid  0700 discharge home with tapered medrol pack, Pepcid, and epi pen.  01/28/21 1800 start of medrol   2/2/21 end of medrol and follow with pcp as needed
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Vision blurred
Clinical narrative: Blurred vision; Eyes burn; Eyes itch; Eyes sting; This is a spontaneous report from a contactable consumer.  A female patient of an unspecified age received the first dose of the bnt162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE), via an unspecified route of administration on an unspecified date at a single dose for COVID-19 immunization.  The patient's medical history and concomitant medications were not reported. On an unspecified date, the patient experienced blurred vision, eyes burn, eyes itch, and eyes sting. The clinical course was reported as follows: The patient stated that she did not know if the events were side effects. The patient just received the first Pfizer vaccine and then went home. When the patient woke up, her vision was blurred; however, the vision cleared up in a very short period of time (in 30 minutes). But ever since the patient had the shot, their eyes burned and itched for two weeks.  The patient did not know if it was something in relation to the vaccine. The clinical outcome of the event, blurred vision, was recovered on an unspecified date. The clinical outcome of the events, eyes burn, eyes itch, and eyes sting, was unknown.  The batch/lot numbers for the vaccine, PFIZER-BIONTECH COVID-19 MRNA VACCINE, were not provided and will be requested during follow up.